Next generation sequencing NGS News and Research

RSS

CRISPR-Cas9-based strategy allows researchers to precisely alter hundreds of different genes

Geneticists have been using model organisms ranging from the house mouse to the single-cell bakers' yeast, Saccharomyces cerevisiae, to study basic biological processes that regulate human development and physiology, and that can be compromised in various diseases.

22 May 2018

Study brings fresh insights into biology of malaria parasite

A team of researchers led by a University of California, Riverside, scientist has found that various stages of the development of human malaria parasites, including stages involved in malaria transmission, are linked to epigenetic features and how chromatin -- the complex of DNA and proteins within the nucleus -- is organized and structured in these parasites.

18 May 2018

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Multiple myeloma is the second most common type of blood cancer in the United States, impacting more than 25,000 people each year and disproportionatly affecting African-American men.

15 May 2018

Scripps researchers awarded two grants to support studies on cocaine, oxycodone addiction

Last year, more than 60,000 Americans died of an opioid overdose, and millions more struggled with opioid and cocaine addiction.

27 Apr 2018

Introduction of the epMotion® 5075 NGS solution for automated library preparation

Eppendorf is introducing a complete package of epMotion 5075 automated liquid handling workstation with all required accessories and related service products that are tailored for the automation of the NGS library preparation.

26 Apr 2018

Coastal Genomics' LightBench integrated with Hamilton liquid handler systems to bring efficiencies, savings for clinical laboratories

Hamilton Robotics is proud to integrate the LightBench with Ranger Technology from Coastal Genomics onto the NIMBUS® Select and all Hamilton liquid handling platforms. Together, they automate DNA protocols and enable fully automated electrophoresis for size selection or quality control. The combination brings efficiencies and savings for clinical laboratories of any size or budget.

From Hamilton Process Analytics 25 Apr 2018

NuProbe to commercialize Wyss Institute's new technology to facilitate precision medicine

NuProbe Global will commercialize the Wyss Institute's DNA nanotechnology-based variant-detecting method as a fast, low-cost and multiplexed molecular diagnostic for different disease areas, including cancer and infectious diseases.

24 Apr 2018

Researchers design creative new approach to regenerate injured hearts

Heart disease is a major global health problem--myocardial infarction annually affects more than one million people in the U.S. alone, and there is still no effective treatment.

24 Apr 2018

SYGNIS AG introduces new TruePrime apoptotic cell free DNA amplification kit

SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.

16 Apr 2018

Agendia receives CE mark for MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, today announces that its next-generation sequencing-based MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit is now CE marked, enabling the Company to commercialize the device in Europe.

22 Mar 2018

Researchers discover 'missing mutation' in severe infant epilepsy

Researchers have discovered a "missing mutation" in severe infant epilepsy--long-suspected genetic changes that might trigger overactive, brain-damaging electrical signaling leading to seizures.

20 Mar 2018

Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis

Today (8 January 2018) at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and consistency of next-generation sequencing data analysis in Genomics England’s Rare Disease Pilot.

From Genomics England 20 Mar 2018

Streamlined workflow could pave way for simple blood test to study cancer heterogeneity in liquid biopsy

Scientists reported the development of a robust and streamlined procedure for whole-genome copy number profiling of circulating tumor cells from a simple blood test.

13 Mar 2018

Precision oncology may improve overall survival, lower healthcare costs for advanced cancer patients

The use of advanced molecular diagnostic technologies, such as Next-Generation Sequencing-based gene panel testing, to select targeted therapies in advanced cancer patients is known as precision oncology.

13 Mar 2018

Oracle Health Sciences study explores status of precision medicine initiatives and challenges

Oracle Health Sciences today announced the results of a new study that explores the current and planned status of precision medicine initiatives, associated challenges and the future impact of this discipline on life sciences and healthcare communities.

7 Mar 2018

BC Platforms' new GeneVision uses Microsoft Genomics Service to deliver end-to-end precision medicine

BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses the Microsoft Genomics service which runs on Microsoft Azure.

7 Mar 2018

Porvair Sciences launches new ChIP-Seq library preparation kit

Porvair Sciences announces the launch of UniqSeq - a new ChIP-Seq library preparation kit. High-quality library preparation is key to a successful ChIP-Seq experiment. Obtaining complex libraries with good coverage and low bias are just some of the features that depend on high-quality DNA after performing ChIP assays.

From Chromatrap® - Porvair Sciences Ltd 7 Mar 2018

Scientists map breast cancer's spread routes

Breast cancer spreads to other organs in the body according to certain specific patterns. This has been shown by a team of researchers from Karolinska Institutet and KTH in Sweden and the University of Helsinki in Finland who have mapped breast cancer's spread routes in patients by studying the cancer cells' DNA. The study is published in The Journal of Clinical Investigation.

27 Feb 2018

Hamilton Robotics Launch ID NIMBUS® for Forensic Genomics Applications

Hamilton Robotics announce the release of the ID NIMBUS® assay ready workstation, specifically pre-configured and qualified to automate post-PCR sample processing using the Verogens renowned ForenSeq DNA Signature Prep Kit.

From Hamilton Process Analytics 26 Feb 2018

New study identifies novel molecular biomarkers of preeclampsia

Preeclampsia, a sudden pregnancy complication that can interfere with the blood flow to the placenta and possibly to the fetus, can lead to low birth weight, prematurity and even death.

22 Feb 2018